WebMay 18, 2024 · Byetta is an injectable diabetes medicine that helps control blood sugar levels. This medication helps your pancreas produce insulin more efficiently. Byetta is a short-acting form of exenatide. Byetta is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes. Byetta is not for treating type 1 diabetes. Webthe needle is left on, BYETTA may leak from the pen and air bubbles may form in the cartridge. Keep your pen and needles out of the reach of children. How long can I use a BYETTA pen? • You can use your BYETTA pen for up to 30 days after setting up a new pen for ˜rst use. After 30 days, throw away the BYETTA pen, even if it is not completely ...
Byetta (Injection Pen) Usage & Safety Guide - Drugs.com
WebByetta is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14)]. Limitations of Use • Byetta is not indicated for use in patients with type 1 … WebJan 5, 2024 · low blood sugar --headache, hunger, sweating, irritability, dizziness, nausea, fast heart rate, and feeling anxious or shaky; or. kidney problems --little or no urination, painful or difficult urination, swelling in your feet or ankles, feeling tired or short of breath. Common side effects may include: alfreton nature reserve
Byetta (Exenatide) for Type 2 Treatment: Comprehensive Review
WebFeb 11, 2024 · Byetta is FDA-approved to help manage blood glucose levels in adult patients with type 2 diabetes, as an adjunct to diet and exercise. Byetta has been studied as monotherapy for type 2 diabetes. WebFeb 27, 2007 · Amylin Pharmaceuticals, Inc.and Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved more convenient patient storage instructions for BYETTA (R) (exenatide) injection. BYETTA Pens can now be kept at a room temperature not to exceed 77 degrees F (25 degrees C) after first use. Webexpanded use for BYETTA as a stand-alone therapy (monotherapy) along with diet and exercise. It was approved as an add-on therapy to insulin glargine in 2011, expanding the indication for the use of BYETTA across the continuum of type 2 diabetes care. BYETTA has a proven history, with millions of prescriptions written. Since market alfreton district